£321k
+122%vs May 2024Active11358447Private limited companyWimborne
VP PHARMA CONSULTANCY LTD
Significant control: Vedran Pavlovic (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Vp Pharma Consultancy Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
VP PHARMA CONSULTANCY LTD is an active private limited company (company number 11358447) incorporated on 12 May 2018, registered in Wimborne. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 May 2025, showing net assets of £321k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 122% on the prior period (£145k).
Peer position · net assets
By net assets it sits in the top quarter of 278 comparable companies in Other (median £129, upper quartile £59k).
02
Ownership and control
- Mr Vedran Pavlovic
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 12 May 20188 yrs ago
- Next accounts due
- 28 February 2027in 128 days
- Confirmation statement due
- 26 May 2027in 215 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
2
No changevs May 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2025 | £321k | — | — | £107k | — | — | 2 |
| 31 May 2024 | £145k | — | — | £61k | — | — | 2 |
Current ratio3.93Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £320,655 at 31 May 2025
- Net assets up 10% or more on the prior period+121.8% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 3.93
- Incorporated five or more years agoIncorporated 12 May 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 215 days
- Next accounts duein 128 days
- Accounts period endNet assets £321k · micro accounts
- Accounts period endNet assets £145k · micro accounts
- Incorporated
08
Similar companies in the UK
- COMPUTATIONAL IMMUNOLOGY RESEARCH AND DEVELOPMENT LTDDereham · inc. May 2018
- C F M D LIMITEDPeterborough · inc. May 2018
- NETHERTON INDUSTRIES LIMITEDYelverton · inc. May 2018
- NCSI CONSULTANCY LTDAylesbury · inc. Jun 2018
- PHYTOME RESEARCH LIMITEDLaunceston · inc. Jun 2018
- DIVERSE TUITION LTDWorcester · inc. Apr 2018
All companies incorporated on 12 May 2018 · in May 2018.
09
Reminders for VP PHARMA CONSULTANCY LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.